Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Joseph Thome is an analyst at TD Cowen. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 03/26/2025
Buy Now | Get Alert | |||||||||
---|---|---|---|---|---|---|---|---|---|---|
11/25/2024 | VRDN | Buy Now | Viridian Therapeutics | $15.54 | — | Joseph Thome34% | — | Initiates | → Buy | Get Alert |
10/25/2024 | MRNS | Buy Now | Marinus Pharma | — | — | Joseph Thome34% | — | Downgrade | Buy → Hold | Get Alert |
10/21/2024 | UTHR | Buy Now | United Therapeutics | $317.50 | 25.98% | Joseph Thome34% | $350 → $400 | Maintains | Buy | Get Alert |
07/11/2024 | UTHR | Buy Now | United Therapeutics | $317.50 | 10.24% | Joseph Thome34% | $270 → $350 | Maintains | Buy | Get Alert |
07/02/2024 | RAPP | Buy Now | Rapport Therapeutics | $9.70 | — | Joseph Thome34% | — | Initiates | → Buy | Get Alert |
06/18/2024 | AVTE | Buy Now | Aerovate Therapeutics | $2.51 | — | Joseph Thome34% | — | Downgrade | Buy → Hold | Get Alert |
06/17/2024 | ALKS | Buy Now | Alkermes | $33.20 | 2.41% | Joseph Thome34% | → $34 | Initiates | → Buy | Get Alert |
04/17/2024 | ITCI | Buy Now | Intra-Cellular Therapies | $131.89 | -31.76% | Joseph Thome34% | $80 → $90 | Maintains | Buy | Get Alert |
04/08/2024 | PRME | Buy Now | Prime Medicine | $1.81 | — | Joseph Thome34% | — | Initiates | → Buy | Get Alert |
03/05/2024 | MGX | Buy Now | Metagenomi | $1.63 | — | Joseph Thome34% | — | Initiates | → Outperform | Get Alert |
03/01/2024 | PTCT | Buy Now | PTC Therapeutics | $56.61 | -47.01% | Joseph Thome34% | $32 → $30 | Maintains | Market Perform | Get Alert |
12/11/2023 | ITCI | Buy Now | Intra-Cellular Therapies | $131.89 | -43.13% | Joseph Thome34% | → $75 | Initiates | → Outperform | Get Alert |
12/08/2023 | CERE | Buy Now | Cerevel Therapeutics Hldg | — | — | Joseph Thome34% | → $45 | Downgrade | Outperform → Market Perform | Get Alert |
10/18/2023 | EVLO | Buy Now | Evelo Biosciences | $0.00 | — | Joseph Thome34% | — | Downgrade | Outperform → Market Perform | Get Alert |
05/24/2023 | PTCT | Buy Now | PTC Therapeutics | $56.61 | -29.34% | Joseph Thome34% | $47 → $40 | Maintains | Market Perform | Get Alert |
04/10/2023 | CERE | Buy Now | Cerevel Therapeutics Hldg | — | — | Joseph Thome34% | — | Initiates | → Outperform | Get Alert |
01/05/2023 | YMAB | Buy Now | Y-mAbs Therapeutics | $5.09 | — | Joseph Thome34% | — | Downgrade | Outperform → Market Perform | Get Alert |
12/12/2022 | XENE | Buy Now | Xenon Pharmaceuticals | $34.60 | — | Joseph Thome34% | — | Initiates | → Outperform | Get Alert |
12/12/2022 | ACRV | Buy Now | Acrivon Therapeutics | $5.02 | — | Joseph Thome34% | — | Initiates | → Outperform | Get Alert |
10/10/2022 | THRD | Buy Now | Third Harmonic Bio | $3.52 | — | Joseph Thome34% | — | Initiates | → Outperform | Get Alert |
06/29/2022 | AXSM | Buy Now | Axsome Therapeutics | $120.36 | 8.01% | Joseph Thome34% | $120 → $130 | Maintains | Outperform | Get Alert |
06/28/2022 | EPZM | Buy Now | Epizyme | — | — | Joseph Thome34% | → $1.5 | Downgrade | Outperform → Market Perform | Get Alert |
01/31/2022 | NTLA | Buy Now | Intellia Therapeutics | $8.88 | — | Joseph Thome34% | — | Initiates | → Outperform | Get Alert |
11/23/2021 | TRDA | Buy Now | Entrada Therapeutics | $10.18 | — | Joseph Thome34% | — | Initiates | → Outperform | Get Alert |
07/26/2021 | AVTE | Buy Now | Aerovate Therapeutics | $2.51 | — | Joseph Thome34% | — | Initiates | → Outperform | Get Alert |
07/15/2021 | ALLK | Buy Now | Allakos | $0.24 | — | Joseph Thome34% | — | Initiates | → Outperform | Get Alert |
07/01/2020 | MRNS | Buy Now | Marinus Pharma | — | — | Joseph Thome34% | — | Initiates | → Outperform | Get Alert |
04/14/2020 | AXSM | Buy Now | Axsome Therapeutics | $120.36 | -21.07% | Joseph Thome34% | → $95 | Initiates | → Outperform | Get Alert |